Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Macrogenics (MGNX) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Macrogenics (MGNX) over the last 13 years, with Q3 2025 value amounting to $0.27.

  • Macrogenics' EPS (Weighted Average and Diluted) fell 7000.0% to $0.27 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2, marking a year-over-year increase of 2405.06%. This contributed to the annual value of -$1.07 for FY2024, which is 61292.17% down from last year.
  • Macrogenics' EPS (Weighted Average and Diluted) amounted to $0.27 in Q3 2025, which was down 7000.0% from -$0.57 recorded in Q2 2025.
  • Macrogenics' 5-year EPS (Weighted Average and Diluted) high stood at $0.92 for Q2 2023, and its period low was -$1.08 during Q1 2022.
  • Its 5-year average for EPS (Weighted Average and Diluted) is -$0.39, with a median of -$0.65 in 2025.
  • As far as peak fluctuations go, Macrogenics' EPS (Weighted Average and Diluted) crashed by 485000.0% in 2021, and later skyrocketed by 23731.34% in 2023.
  • Quarter analysis of 5 years shows Macrogenics' EPS (Weighted Average and Diluted) stood at -$0.95 in 2021, then surged by 122.11% to $0.21 in 2022, then tumbled by 457.14% to -$0.75 in 2023, then soared by 67.17% to -$0.25 in 2024, then surged by 209.64% to $0.27 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at $0.27 for Q3 2025, versus -$0.57 for Q2 2025 and -$0.65 for Q1 2025.